Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)

Bausch Health Companies (BHC) reported Current Deferred Tax Assets of $727.2 million for Q3 2015, up 129.84% on a YoY basis from $316.4 million in Q3 2014, and up 2.22% sequentially from $711.4 million in Q2 2015.

Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends

Bausch Health Companies (BHC) has 6 years of Current Deferred Tax Assets data on file, last reported at $727.2 million in Q3 2015.

  • For the quarter ending Q3 2015, Current Deferred Tax Assets rose 129.84% year-over-year to $727.2 million; the trailing twelve-month figure through Sep 2015 stood at $727.2 million (up 129.84% YoY), and the FY2014 full-year result was $193.3 million, down 47.32% from the prior year.
  • Current Deferred Tax Assets improved to $727.2 million in Q3 2015, from $711.4 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $727.2 million in Q3 2015 to a low of $77.5 million in Q3 2011.
  • A 5-year average of $255.6 million and a median of $196.8 million in 2012 frame the typical range for Current Deferred Tax Assets.
  • Across the five-year window, Current Deferred Tax Assets jumped 540.48% in 2011 and plunged 47.32% in 2014, its largest moves.
  • Tracing BHC's Current Deferred Tax Assets over 5 years: stood at $148.5 million in 2011, then surged by 31.36% to $195.0 million in 2012, then soared by 88.15% to $366.9 million in 2013, then tumbled by 47.32% to $193.3 million in 2014, then soared by 276.2% to $727.2 million in 2015.
  • Business Quant data shows BHC's Current Deferred Tax Assets at $727.2 million in Q3 2015, $711.4 million in Q2 2015, and $193.3 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn

Historic Data

Download Data
DateValue
Sep 30, 2015 727.20 Mn
Sep 30, 2015 727.20 Mn
Jun 30, 2015 711.40 Mn
Jun 30, 2015 711.40 Mn
Dec 31, 2014 193.30 Mn
Dec 31, 2014 193.30 Mn
Sep 30, 2014 316.40 Mn
Sep 30, 2014 316.40 Mn
Jun 30, 2014 309.80 Mn
Jun 30, 2014 309.80 Mn
Mar 31, 2014 315.30 Mn
Mar 31, 2014 315.30 Mn
Dec 31, 2013 366.90 Mn
Dec 31, 2013 366.90 Mn
Sep 30, 2013 221.93 Mn
Sep 30, 2013 221.93 Mn
Jun 30, 2013 198.67 Mn
Jun 30, 2013 198.67 Mn
Mar 31, 2013 198.88 Mn
Mar 31, 2013 198.88 Mn